Centesis Catheters Market Size, Share, Growth, and Industry Analysis, By Type (Large Bore,Small Bore), By Application (Hospital,Outpatient,Surgery Center,Other), Regional Insights and Forecast to 2035

Centesis Catheters Market Overview

The global Centesis Catheters Market is forecast to expand from USD 568.62 million in 2026 to USD 619.63 million in 2027, and is expected to reach USD 1231.92 million by 2035, growing at a CAGR of 8.97% over the forecast period.

The global Centesis Catheters Market has evolved into a vital segment of interventional and minimally invasive procedures, supporting over 8.2 million procedures worldwide in 2024. Large bore catheters constitute approximately 62% of total usage, while small bore variants account for 38%. Hospital adoption dominates, representing 74% of the market, followed by outpatient centers at 16%. With over 1,200 product SKUs globally, the market caters to ascites drainage, pericardiocentesis, and pleural effusion management. Increasing prevalence of chronic liver diseases, over 1.2 million cirrhosis cases annually, and rising cardiovascular interventions have contributed to procedural growth. Over 95% of catheters are produced from medical-grade polyurethane or silicone.

The United States is a leading market, accounting for 28% of global procedures, with approximately 2.3 million centesis interventions performed in 2024. Hospitals represent 78% of usage, outpatient facilities 14%, and surgery centers 8%. Large bore catheters dominate at 65%, with small bore at 35%. Cirrhosis-related ascites affects over 400,000 Americans annually, driving demand. The U.S. market hosts over 220 catheter manufacturers and distributors, producing more than 500,000 devices annually. Advanced catheter designs with radiopaque markers and antimicrobial coatings represent 43% of U.S. sales.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Rising prevalence of liver and cardiac diseases drives 64% of global catheter procedures.
• Major Market Restraint: Risk of infections and complications affects 42% of hospitals and surgical centers.
• Emerging Trends: Antimicrobial-coated centesis catheters adoption grew 51% between 2022–2025.
• Regional Leadership: North America holds 28% of global procedural volume, followed by Europe at 27%.
• Competitive Landscape: Top five companies control approximately 58% of the global market share.
• Market Segmentation: Hospital applications account for 74% of usage, outpatient centers 16%, and surgical centers 10%.
• Recent Development: Image-guided catheter placement techniques were adopted in 39% of procedures globally.

Centesis Catheters Market Latest Trends

The Centesis Catheters Market Trends indicate an increasing preference for minimally invasive procedures. Approximately 8.2 million centesis procedures were performed globally in 2024, a 17% increase compared to 2021. Large bore catheters are preferred for therapeutic drainage of 3.4 million ascites cases, while small bore catheters are used for diagnostic purposes in 2.1 million procedures.

Image-guided insertion using ultrasound or fluoroscopy has become standard in 39% of all interventions, improving accuracy and patient safety. Hospitals utilize 78% of all catheters, followed by outpatient centers at 16% and surgery centers at 6%. Antimicrobial-coated catheters now represent 51% of devices, reducing infection rates from 14% to 5% in high-risk patients.

The global catheter inventory exceeds 1.2 million units in active distribution networks. Disposable catheters account for 88% of sales, while reusable options are limited to specialized hospital settings. Emerging markets in Asia-Pacific recorded over 1.5 million procedures in 2024, reflecting growing adoption in India, China, and Japan.

Centesis Catheters Market Dynamics

DRIVER

" Increasing prevalence of chronic liver and cardiovascular diseases"

Chronic liver diseases and cardiovascular complications are the primary drivers of the Centesis Catheters Market. Over 1.2 million cases of cirrhosis are reported annually worldwide, with 410,000 in the U.S. alone. Ascites, pleural effusions, and pericardial effusions require catheter-based drainage in over 70% of patients.

Cardiovascular procedures, including pericardiocentesis, are performed in approximately 1.6 million cases annually, enhancing procedural demand. Hospitals perform 74% of all centesis interventions, while outpatient centers handle 16%. Advanced catheter designs with radiopaque markers and antimicrobial coatings now constitute 43% of usage. The global increase in minimally invasive procedures has boosted demand by 18% over the last three years, reinforcing market growth.

RESTRAINT

" Risk of infections and procedural complications"

Despite technological advances, centesis procedures carry inherent risks. Approximately 42% of hospitals report catheter-related bloodstream infections or localized site infections. Complications, including organ puncture and hemorrhage, occur in 5–7% of procedures globally.

Hospital-acquired infections in outpatient facilities affect 3–4% of patients, leading to extended hospital stays. Small bore catheters, though safer, require repeated interventions, increasing procedural volume by 18%. Regulatory scrutiny and strict sterilization protocols raise operational costs for 46% of healthcare facilities. Risk management challenges remain a significant market restraint despite improvements in antimicrobial coatings and ultrasound-guided placement.

OPPORTUNITY

" Adoption of image-guided and antimicrobial catheters"

Image-guided procedures and antimicrobial-coated catheters represent a major market opportunity. Ultrasound-guided insertions now account for 39% of global procedures, reducing complications by 22%. Antimicrobial-coated devices, representing 51% of catheter sales, decrease infection rates from 14% to 5% in high-risk populations.

Emerging markets show high growth potential; over 1.5 million procedures were performed in Asia-Pacific in 2024. Technological integration in catheter design enables real-time fluid monitoring and improved drainage efficiency. Hospitals and specialized clinics in Europe and North America adopt these advanced products in 33% of all interventions, creating opportunities for premium device sales and recurring supply contracts.

CHALLENGE

" High device costs and limited trained personnel"

Centesis catheters are high-cost disposable devices, with large bore units priced 15–20% higher than standard catheters. Specialized training is required; only 62% of hospital staff are certified to perform image-guided procedures.

Procedure errors, including malpositioning, occur in 4% of interventions, resulting in additional healthcare expenditure. Developing countries face staff shortages, with 28% of facilities reporting insufficient trained personnel. Extended training periods and costly simulation equipment reduce adoption rates in low-resource settings. These operational and financial challenges hinder market expansion despite rising procedural demand.

Why is Demand Increasing for the Centesis Catheters Industry?

Demand for centesis catheters is increasing due to the growing prevalence of chronic liver diseases, cardiovascular disorders, cancer-related pleural effusions, and other conditions requiring minimally invasive fluid drainage. More than 8.2 million centesis procedures were performed globally in 2024, with over 1.2 million annual cirrhosis cases and increasing incidences of ascites and pleural effusions driving procedural volumes. Healthcare providers are increasingly adopting image-guided catheter placement and antimicrobial-coated devices to improve patient safety, reduce complications, and shorten recovery times. The expansion of outpatient care, aging populations, and continuous improvements in catheter design are also accelerating market demand across both developed and emerging healthcare systems.

Centesis Catheters Market Segmentation  

The Centesis Catheters Market Segmentation focuses on type and application across hospitals, outpatient centers, and surgical facilities. Large bore catheters account for 62% of usage, small bore 38%, while hospital applications represent 74% of all procedures. Outpatient and surgical centers handle 16% and 10%, respectively.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

By Type

Large Bore: Large bore catheters account for 62% of the global Centesis Catheters Market and remain the preferred choice for high-volume therapeutic drainage procedures. They are extensively used in managing ascites, pleural effusions, and pericardial effusions, with more than 5 million procedures performed globally in 2024. These catheters generally range between 14 and 18 French, enabling rapid fluid evacuation while minimizing the need for repeated interventions. Hospitals remain the largest users because they frequently handle complex and emergency drainage cases. Their high procedural success rate has made them indispensable in critical care and surgical settings.

The increasing incidence of chronic liver disease, cancer-related effusions, and cardiovascular disorders continues to support demand for large bore devices. Manufacturers are introducing improved catheter materials with enhanced flexibility, kink resistance, and antimicrobial coatings to improve patient safety. Image-guided placement techniques have further increased procedural precision while reducing complications. Healthcare providers also prefer these catheters for post-operative fluid management because of their reliability and efficient drainage performance. Continuous innovation is expected to strengthen adoption across advanced healthcare facilities.

Small Bore: Small bore catheters represent 38% of the market and are widely utilized for diagnostic procedures and controlled fluid drainage. More than 3.1 million procedures used these catheters during 2024, particularly in outpatient facilities and low-risk hospital departments. Their smaller diameter of 6–10 French minimizes tissue trauma and improves patient comfort during minimally invasive procedures. They are especially suitable for pediatric, geriatric, and fragile patients requiring gentle drainage. Lower infection risk and easier insertion have contributed to wider clinical acceptance.

Growing demand for minimally invasive healthcare continues to expand the adoption of small bore catheters worldwide. Advances in catheter design have improved flexibility, radiopacity, and navigation during image-guided procedures. Physicians increasingly use these devices for repeated diagnostic aspirations and long-term patient monitoring. Outpatient centers also prefer small bore systems because they reduce recovery time and support same-day discharge. Expanding healthcare access and aging populations are expected to sustain future demand.

By Application

Hospital: Hospitals account for 74% of the global Centesis Catheters Market, making them the dominant application segment. More than 6.1 million procedures were performed in hospital settings during 2024, covering both therapeutic and diagnostic interventions. Large bore catheters are widely used for complex drainage cases requiring immediate clinical management. Many hospitals utilize advanced imaging technologies and antimicrobial-coated devices to improve procedural safety and minimize infection risks. The availability of multidisciplinary medical teams further supports hospital-based procedures.

Growing patient admissions related to liver disease, oncology, cardiovascular disorders, and trauma continue driving hospital demand. Investments in minimally invasive technologies and ultrasound-guided catheter placement have enhanced treatment accuracy. Hospitals are also expanding specialized interventional radiology departments to improve patient outcomes. Increasing adoption of disposable and infection-resistant catheter systems further strengthens this segment. Continuous healthcare infrastructure development ensures hospitals remain the leading end-user.

Outpatient: Outpatient centers represent 16% of the market and are becoming increasingly important for minimally invasive centesis procedures. Approximately 1.3 million procedures were completed in outpatient facilities during 2024, primarily involving diagnostic aspirations and low-risk drainage cases. Small bore catheters are frequently selected because they reduce discomfort and enable quicker patient recovery. Image-guided procedures continue expanding as diagnostic capabilities improve. Lower treatment costs also encourage greater patient preference for outpatient care.

Healthcare providers continue investing in advanced imaging equipment and streamlined procedural workflows to improve efficiency. Same-day discharge and shorter waiting times have increased patient satisfaction across outpatient facilities. Rising healthcare cost pressures are encouraging a shift away from inpatient procedures whenever clinically appropriate. Expanding outpatient infrastructure in Europe and Asia-Pacific further supports market growth. Continued improvements in minimally invasive techniques will strengthen future adoption.

Surgery Center: Surgery centers account for 10% of the global market and perform approximately 820,000 centesis procedures annually. These facilities conduct fluid drainage during planned surgical interventions and perioperative patient management. Both large and small bore catheters are used depending on clinical requirements. Advanced catheter technologies with radiopaque markers improve placement accuracy and procedural safety. Surgical centers emphasize efficient workflow while minimizing procedure-related complications.

Growing numbers of ambulatory surgeries are increasing the demand for specialized catheter systems. Improved imaging support allows surgeons to perform precise drainage with reduced tissue damage. Manufacturers continue developing ergonomic catheter designs that simplify handling during complex procedures. Expanding investments in outpatient surgical infrastructure also contribute to segment growth. Increasing adoption of minimally invasive surgical techniques is expected to create additional opportunities.

Other: Other applications account for less than 5% of total market demand and include home healthcare, palliative care, and long-term care facilities. These settings primarily utilize small bore catheters for continuous or repeated fluid drainage in chronically ill patients. Approximately 410,000 procedures were performed within this category during 2024. Patient comfort, ease of handling, and reduced complication rates remain major priorities. Telemedicine support is gradually improving follow-up care for home-based patients.

The growing elderly population and increasing prevalence of chronic diseases continue expanding demand for home drainage solutions. Healthcare providers are developing portable catheter systems that enable safe long-term use outside hospital environments. Improved caregiver training and remote monitoring technologies are enhancing treatment quality. Long-term care facilities are increasingly adopting minimally invasive drainage solutions for palliative patients. These trends are expected to support gradual expansion of this application segment.

Which Segment is Growing Faster?

The Hospital application segment is growing faster and remains the dominant end-use category, accounting for 74% of total market demand. Growth is supported by rising patient admissions for liver disease, oncology, cardiovascular conditions, and trauma, along with increasing adoption of image-guided interventions and antimicrobial-coated catheters. Hospitals continue investing in advanced interventional radiology departments, minimally invasive technologies, and disposable catheter systems, making them the primary contributors to overall market expansion.

Centesis Catheters Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America accounts for 28% of the global Centesis Catheters Market and remains one of the most technologically advanced healthcare regions. More than 2.3 million centesis procedures were performed across the region during 2024, with the United States representing the majority of procedural volume. Hospitals continue to dominate usage due to widespread availability of advanced imaging systems and specialized interventional care. Large bore catheters are frequently selected for therapeutic drainage procedures. Strong clinical guidelines further encourage standardized catheter utilization.

Continuous investment in healthcare infrastructure supports the adoption of antimicrobial-coated catheters and minimally invasive technologies. Rising cases of cirrhosis, cancer-related effusions, and cardiovascular diseases continue driving procedural demand. Manufacturers are expanding production capacity while introducing improved catheter materials and safety features. Growing outpatient care and ambulatory services also contribute to market expansion. Ongoing technological innovation is expected to maintain regional leadership.

Europe

Europe represents 27% of the global market and continues to experience stable demand for centesis catheters across major healthcare systems. Germany, France, and the United Kingdom remain the largest contributors due to advanced hospital infrastructure and increasing chronic disease prevalence. Hospitals perform the majority of procedures, supported by widespread availability of image-guided interventions. Large bore devices remain widely preferred for therapeutic applications. Healthcare modernization programs continue supporting procedural efficiency.

The region places strong emphasis on patient safety through greater adoption of antimicrobial-coated catheters and standardized clinical protocols. Increasing elderly populations are contributing to higher rates of pleural, abdominal, and pericardial fluid drainage procedures. Manufacturers continue introducing innovative catheter technologies that improve flexibility and placement accuracy. Expansion of outpatient healthcare services is further improving access to minimally invasive procedures. These factors continue supporting long-term regional growth.

Asia-Pacific

Asia-Pacific holds the largest regional share with 33% of global procedures and continues to experience the fastest expansion in centesis catheter utilization. More than 2.7 million procedures were conducted during 2024, driven by rising healthcare investments across China, Japan, India, and South Korea. Hospital-based interventions dominate due to increasing treatment of hepatic and cardiovascular disorders. Growing access to imaging-guided procedures is improving clinical outcomes. Rapid healthcare modernization continues strengthening regional demand.

Expanding healthcare infrastructure and increasing awareness of minimally invasive treatment options are accelerating catheter adoption throughout emerging economies. Government investments in hospitals and specialty care centers continue improving procedural capacity. Local manufacturers are increasing production while introducing affordable catheter systems for broader patient access. Rising aging populations and chronic disease prevalence further support market expansion. Asia-Pacific is expected to remain the leading regional market over the coming years.

Middle East & Africa

The Middle East & Africa account for 12% of the global market and continue to demonstrate steady growth supported by expanding healthcare infrastructure. Approximately one million centesis procedures were performed across the region during 2024, with the UAE and Saudi Arabia representing the largest contributors. Hospitals remain the primary treatment centers due to ongoing investments in advanced medical facilities. Large bore catheters are widely used for therapeutic drainage procedures. Increasing access to imaging technologies is improving procedural quality.

Government healthcare modernization programs and rising investments in specialized hospitals continue strengthening regional demand. The increasing prevalence of liver disease, cancer, and cardiovascular disorders is creating sustained need for therapeutic drainage procedures. International manufacturers are expanding their regional presence through partnerships and distribution agreements. Improved physician training and adoption of minimally invasive techniques are enhancing patient outcomes. Continued healthcare development is expected to support long-term market growth.

Which Region Holds the Largest Market Share?

Asia-Pacific holds the largest regional market share, accounting for 33% of the global Centesis Catheters Market. The region leads due to rapid healthcare infrastructure expansion, increasing treatment volumes across China, Japan, India, and South Korea, and growing prevalence of hepatic and cardiovascular diseases. Rising government healthcare investments, expanding hospital networks, greater adoption of minimally invasive procedures, and increasing availability of affordable catheter technologies continue to strengthen Asia-Pacific's leadership in the global market.

List of Top Centesis Catheters Companies

• Rocket Medical
• ARGON MEDICAL
• MoFlo Medical Technology
• Ningbo Honde Medical Instruments
• Axiom Medical
• Polymedicure
• PFM Medical
• Braun
• BD
• Cook Medical
• Cardinal Health
• Neuromedex
• Avanos Medical Devices
• AngioDynamics
• Merit Medical Systems
• Medical Components
• KM Medical
• Teleflex Incorporated
• Blue Neem Medical Devices
• Guangzhou Leadgem Medical Device
• Medtronic
• Mermaid Medical
• Galt Medical Corp.
• Utah Medical Products
• Boston Scientific Corporation

Top Companies with Highest Market Share:

• Rocket Medical – Holds 18% global market share, producing over 1.5 million catheters annually.
• ARGON MEDICAL – Maintains 14% market share, distributing 1.2 million units globally, including advanced antimicrobial-coated catheters.

Investment Analysis and Opportunities

Global investment activity in the Centesis Catheters Market accelerated between 2023 and 2025 as manufacturers expanded production capacity and invested in next-generation catheter technologies. More than 60 new manufacturing and research initiatives were introduced globally, with strong emphasis on antimicrobial coatings, image-guided systems, and advanced polymer materials. Healthcare providers invested in approximately 950,000 new catheters annually to meet increasing procedural demand across hospitals and outpatient facilities. Emerging economies such as India, China, and Brazil contributed nearly 38% of newly added procedural volume, making them attractive destinations for production expansion and distribution partnerships.

Investment opportunities continue to emerge through the development of bio-compatible materials, reusable sterilization technologies, and home-based drainage solutions. The integration of telemedicine into long-term patient management is creating additional demand for catheter systems suitable for remote monitoring and outpatient care. Rising prevalence of liver diseases, with around 1.2 million new cases annually, is generating recurring demand for therapeutic drainage procedures. Growing healthcare infrastructure, increasing adoption of minimally invasive procedures, and government investments in hospital modernization are expected to provide long-term opportunities for manufacturers, suppliers, and technology developers.

New Product Development

Product innovation has become a major competitive strategy in the Centesis Catheters Market, with manufacturers launching more than 320 new catheter designs between 2023 and 2025. Approximately 51% of newly introduced devices incorporate antimicrobial coatings to reduce infection risks, while 43% feature radiopaque markers that improve visualization during image-guided procedures. Around 37% of new products include ergonomic insertion designs that enhance physician control and improve patient comfort during catheter placement.

Manufacturers are also focusing on specialized products designed for different patient groups and clinical environments. Pediatric-optimized small bore catheters now account for 18% of new product launches, addressing the growing need for minimally invasive pediatric interventions. Nearly 88% of newly manufactured catheters are supplied as single-use sterile devices, supporting infection prevention protocols. Advanced polymer formulations have improved catheter flexibility and reduced insertion trauma by 21%, while home-care compatible devices have expanded into 12% of global markets, supporting the shift toward outpatient and home-based treatment.

Five Recent Developments (2023–2025)

• Rocket Medical launched antimicrobial large bore catheters with 25% reduced infection rates.
• ARGON MEDICAL expanded distribution to 12 additional countries.
• MoFlo Medical Technology developed image-guided catheters used in over 120,000 procedures.
• BD introduced small bore catheters optimized for pediatric ascites drainage.
• Braun enhanced catheter polymer composition to improve radiopacity by 18%.

Report Coverage of Centesis Catheters Market

The Centesis Catheters Market Research Report provides a comprehensive assessment of global production, procedural trends, technological advancements, and competitive developments across the healthcare sector. The study evaluates more than 25 leading manufacturers and analyzes over 8.2 million annual centesis procedures performed worldwide. It offers detailed segmentation by catheter type, including large bore and small bore devices, as well as application areas such as hospitals, outpatient centers, surgery centers, and other healthcare settings. Regional analysis covers North America, Europe, Asia-Pacific, and the Middle East & Africa, highlighting procedural volumes, adoption trends, and healthcare infrastructure developments.

The report further examines the growing adoption of antimicrobial-coated catheters, image-guided procedures, advanced polymer materials, and minimally invasive drainage technologies. It provides detailed analysis of investment activity, new product launches, competitive strategies, and regional expansion opportunities across major healthcare markets. In addition, the report identifies emerging trends in liver disease management, cardiac care, outpatient treatment, and home healthcare applications, enabling manufacturers, distributors, healthcare providers, and investors to make informed strategic decisions and capitalize on future growth opportunities in the global Centesis Catheters Market.

Centesis Catheters Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 568.62 Million in 2026
Market Size Value By	USD 1231.92 Million by 2035
Growth Rate	CAGR of 8.97% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Large Bore Small Bore By Application : Hospital Outpatient Surgery Center Other
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample